用实验和计算方法评估与平衡核酸转运体1和2的分子相互作用
Lucy J Martinez-Guerrero1, Patricia A Vignaux2, Dominique O Farrera1
1College of Pharmacy, Department of Pharmacology & Toxicology, University of Arizona, Tucson, Arizona.
The Journal of pharmacology and experimental therapeutics
|August 8, 2025
概括
研究人员选了1600多种化合物,以确定平衡核酸转运体 (ENT) 抑制剂. 机器学习模型预测了新的ENTT1抑制剂,包括FDA批准的药物,有助于早期药物发现.
科学领域:
- 生物化学和分子生物学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 平衡性核酸转运体 (ENTs) 通过细胞膜中介于核酸和核转运.
- ENT1 (SLC29A1) 和ENT2 (SLC29A2) 在癌症,病毒和炎症疾病中对药物药理动力学/药理动力学至关重要.
- 通过对甲氨酸 (NBMPR) 的敏感性来区分ENT1和ENT2功能,可以进行有针对性的测定.
研究的目的:
- 选一个大型的图书馆,各种各样的化合物用于ENT1和ENT2抑制.
- 开发和验证用于预测 ENT 抑制剂的机器学习模型.
- 确定新的抑制剂,包括FDA批准的药物,用于临床相关的载体.
主要方法:
- 对1600种不同的化合物进行对ENT1和ENT2的选.
- 开发机器学习模型,使用数据集平衡和符合性预测.
- 通过预测抑制剂在单独的药物重定向库中验证模型.
主要成果:
- 确定伊斯拉迪平,阿瓦纳菲尔和伊斯特拉迪菲林作为新型ENT1抑制剂.
- 机器学习模型准确地预测了潜在的ENT1抑制剂.
- 一种结合实验和计算方法的方法成功地确定了药物抑制剂.
结论:
- 开发的实验和计算方法为评估药物-载体相互作用提供了一个强大的平台.
- 药物载体相互作用的早期识别可以显著影响药物发现管道.
- 这项研究确定了FDA批准的药物作为ENTT1和ENT2的抑制剂,突出了它们对药物重新用途的潜力.
更多相关视频
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
2.0K
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10.1K
相关概念视频
01:17Pore Transport and Ion-Pair Transport
644
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
644
01:44The Significance of Membrane Transport
29.6K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
29.6K
01:24Cellular Membranes and Drug Transport
949
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
949
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.5K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.5K
01:06Carrier-Mediated Transport
547
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
547
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
80
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
80